Well, I can speak for quite a few minutes on that.
I mentioned earlier the drugs for rare diseases strategy, which we announced just a few weeks ago, a $1.5-billion investment over the next three years. This is going to give Canadians with rare diseases—including thousands and tens of thousands of children, their caregivers, their families—access to those essential drugs that can be life-saving and can certainly help them to live a life that is as normal as possible.
That is not mentioning the Canadian drug agency that we are setting up, which is going to bring prices down through a national formulary, through bulk purchasing—